These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 30858603)

  • 1. In vivo neuronal gene editing via CRISPR-Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer's disease.
    Park H; Oh J; Shim G; Cho B; Chang Y; Kim S; Baek S; Kim H; Shin J; Choi H; Yoo J; Kim J; Jun W; Lee M; Lengner CJ; Oh YK; Kim J
    Nat Neurosci; 2019 Apr; 22(4):524-528. PubMed ID: 30858603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-340 Reduces the Accumulation of Amyloid-β Through Targeting BACE1 (β-site Amyloid Precursor Protein Cleaving Enzyme 1) in Alzheimer's Disease.
    Tan X; Luo Y; Pi D; Xia L; Li Z; Tu Q
    Curr Neurovasc Res; 2020; 17(1):86-92. PubMed ID: 31957613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic delivery of BACE1 siRNA through neuron-targeted nanocomplexes for treatment of Alzheimer's disease.
    Wang P; Zheng X; Guo Q; Yang P; Pang X; Qian K; Lu W; Zhang Q; Jiang X
    J Control Release; 2018 Jun; 279():220-233. PubMed ID: 29679667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice.
    Devi L; Ohno M
    Eur J Neurosci; 2010 Jan; 31(1):110-8. PubMed ID: 20092558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR/Cas9 editing of APP C-terminus attenuates β-cleavage and promotes α-cleavage.
    Sun J; Carlson-Stevermer J; Das U; Shen M; Delenclos M; Snead AM; Koo SY; Wang L; Qiao D; Loi J; Petersen AJ; Stockton M; Bhattacharyya A; Jones MV; Zhao X; McLean PJ; Sproul AA; Saha K; Roy S
    Nat Commun; 2019 Jan; 10(1):53. PubMed ID: 30604771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases.
    Cai Z; Wang C; He W; Chen Y
    Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of BACE1 S-palmitoylation reduces amyloid burden and mitigates memory deficits in transgenic mouse models of Alzheimer's disease.
    Andrew RJ; Fernandez CG; Stanley M; Jiang H; Nguyen P; Rice RC; Buggia-Prévot V; De Rossi P; Vetrivel KS; Lamb R; Argemi A; Allaert ES; Rathbun EM; Krause SV; Wagner SL; Parent AT; Holtzman DM; Thinakaran G
    Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9665-E9674. PubMed ID: 29078331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic administration of fibroblast growth factor-2 (FGF2) reduces BACE1 expression and amyloid pathology in APP23 mice.
    Katsouri L; Ashraf A; Birch AM; Lee KK; Mirzaei N; Sastre M
    Neurobiol Aging; 2015 Feb; 36(2):821-31. PubMed ID: 25457554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aβ reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level.
    Sadleir KR; Eimer WA; Cole SL; Vassar R
    Mol Neurodegener; 2015 Jan; 10():1. PubMed ID: 25567526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-29c targets β-site amyloid precursor protein-cleaving enzyme 1 and has a neuroprotective role in vitro and in vivo.
    Yang G; Song Y; Zhou X; Deng Y; Liu T; Weng G; Yu D; Pan S
    Mol Med Rep; 2015 Aug; 12(2):3081-8. PubMed ID: 25955795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The BACE1-Specific DNA Aptamer A1 Rescues Amyloid-β Pathology and Behavioral Deficits in a Mouse Model of Alzheimer's Disease.
    Liang ZM; Peng YH; Chen Y; Long LL; Luo HJ; Chen YJ; Liang YL; Tian YH; Li SJ; Shi YS; Zhang XM
    Nucleic Acid Ther; 2019 Dec; 29(6):359-366. PubMed ID: 31513457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid β Protein Aggravates Neuronal Senescence and Cognitive Deficits in 5XFAD Mouse Model of Alzheimer's Disease.
    Wei Z; Chen XC; Song Y; Pan XD; Dai XM; Zhang J; Cui XL; Wu XL; Zhu YG
    Chin Med J (Engl); 2016 Aug; 129(15):1835-44. PubMed ID: 27453234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knock-in of human BACE1 cleaves murine APP and reiterates Alzheimer-like phenotypes.
    Plucińska K; Crouch B; Koss D; Robinson L; Siebrecht M; Riedel G; Platt B
    J Neurosci; 2014 Aug; 34(32):10710-28. PubMed ID: 25100603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice.
    He P; Zhong Z; Lindholm K; Berning L; Lee W; Lemere C; Staufenbiel M; Li R; Shen Y
    J Cell Biol; 2007 Aug; 178(5):829-41. PubMed ID: 17724122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR Transcriptional Activation Analysis Unmasks an Occult γ-Secretase Processivity Defect in Familial Alzheimer's Disease Skin Fibroblasts.
    Inoue K; Oliveira LMA; Abeliovich A
    Cell Rep; 2017 Nov; 21(7):1727-1736. PubMed ID: 29141208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain pyroglutamate amyloid-β is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer's disease therapeutic.
    Hook G; Yu J; Toneff T; Kindy M; Hook V
    J Alzheimers Dis; 2014; 41(1):129-49. PubMed ID: 24595198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NRF2/ARE pathway negatively regulates BACE1 expression and ameliorates cognitive deficits in mouse Alzheimer's models.
    Bahn G; Park JS; Yun UJ; Lee YJ; Choi Y; Park JS; Baek SH; Choi BY; Cho YS; Kim HK; Han J; Sul JH; Baik SH; Lim J; Wakabayashi N; Bae SH; Han JW; Arumugam TV; Mattson MP; Jo DG
    Proc Natl Acad Sci U S A; 2019 Jun; 116(25):12516-12523. PubMed ID: 31164420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease.
    Sadleir KR; Kandalepas PC; Buggia-Prévot V; Nicholson DA; Thinakaran G; Vassar R
    Acta Neuropathol; 2016 Aug; 132(2):235-256. PubMed ID: 26993139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disrupted-in-Schizophrenia-1 Attenuates Amyloid-β Generation and Cognitive Deficits in APP/PS1 Transgenic Mice by Reduction of β-Site APP-Cleaving Enzyme 1 Levels.
    Deng QS; Dong XY; Wu H; Wang W; Wang ZT; Zhu JW; Liu CF; Jia WQ; Zhang Y; Schachner M; Ma QH; Xu RX
    Neuropsychopharmacology; 2016 Jan; 41(2):440-53. PubMed ID: 26062786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.